Order Article Reprints

Yadav R, Sukumaran S, Zabka TS, Li J, Oldendorp A, Morrow G, Reyes A, Cheu M, Li J, Wallin JJ, et al. Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies. Pharmaceutics. 2022; 14(5):970. https://doi.org/10.3390/pharmaceutics14050970

Yadav, Rajbharan, Siddharth Sukumaran, Tanja S. Zabka, Jinze Li, Amy Oldendorp, Gary Morrow, Arthur Reyes, Melissa Cheu, Jessica Li, Jeffrey J. Wallin, and et al. 2022. "Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies" Pharmaceutics 14, no. 5: 970. https://doi.org/10.3390/pharmaceutics14050970

Yadav, R., Sukumaran, S., Zabka, T. S., Li, J., Oldendorp, A., Morrow, G., Reyes, A., Cheu, M., Li, J., Wallin, J. J., Tsai, S., Sun, L., Wang, P., Ellerman, D., Spiess, C., Polson, A., Stefanich, E. G., Kamath, A. V., & Ovacik, M. A. (2022). Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies. Pharmaceutics, 14(5), 970. https://doi.org/10.3390/pharmaceutics14050970